Photoacoustic imaging of stimuli-responsive red blood cell drug delivery agents

Author(s):  
Adam Dixon ◽  
Justin Farry ◽  
Johnny Chen ◽  
Ali H. Dhanaliwala ◽  
John A. Hossack ◽  
...  
1994 ◽  
Vol 2 (4) ◽  
pp. 341-347 ◽  
Author(s):  
Ruth Duncan ◽  
Paolo Ferruti ◽  
Dionyssios Sgouras ◽  
Anthony Tuboku-Metzger ◽  
Elisabetta Ranucci ◽  
...  

2021 ◽  
Author(s):  
Fayruz Kibria

Red blood cell (RBC) aggregation was correctly reported in early 1768 as the increased deposition for blood to form spots of red in pathological conditions. However only recently have there been advances in technology to allow possible detection of RBC aggregation in vivo. Photoacoustic imaging (PA) shows a promising future in the detection of simultaneous in vivo RBC aggregation and oxygen saturation. This work presents, for the first time, the results of investigating aggregated RBCs using high frequency (> 20 MHz) photoacoustic (PA) imaging. Aggregation was induced by using 3% w/v concentration of 70 kDa Dextran and PA measurements were taken by a 25 MHz center frequency transducer. It was found that the spectral slope (SS) of the photoacoustic signals decreased by ~0.25 dB/MHz with RBC aggregation. The results are consistent with the findings of low frequency PA RBC aggregation study which also reported decrease in SS with increased aggregation.


2018 ◽  
Vol 9 (1) ◽  
Author(s):  
Waqas Muhammad Usman ◽  
Tin Chanh Pham ◽  
Yuk Yan Kwok ◽  
Luyen Tien Vu ◽  
Victor Ma ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Wararat Chiangjong ◽  
Pukkavadee Netsirisawan ◽  
Suradej Hongeng ◽  
Somchai Chutipongtanate

Recently, red blood cell-derived extracellular vesicles (RBCEVs) have attracted attention for clinical applications because of their safety and biocompatibility. RBCEVs can escape macrophages through the binding of CD47 to inhibitory receptor signal regulatory protein α. Furthermore, genetic materials such as siRNA, miRNA, mRNA, or single-stranded RNA can be encapsulated within RBCEVs and then released into target cells for precise treatment. However, their side effects, half-lives, target cell specificity, and limited large-scale production under good manufacturing practice remain challenging. In this review, we summarized the biogenesis and composition of RBCEVs, discussed the advantages and disadvantages of RBCEVs for drug delivery compared with synthetic nanovesicles and non-red blood cell-derived EVs, and provided perspectives for overcoming current limitations to the use of RBCEVs for clinical applications.


Nanoscale ◽  
2021 ◽  
Author(s):  
Mehdi Nikfar ◽  
Meghdad Razizadeh ◽  
Ratul Paul ◽  
Vladimir N Muzykantov ◽  
Yaling Liu

Red blood cell (RBC)-hitchhiking, in which different nanocarriers (NCs) shuttled on the erythrocyte membrane and disassociated from RBCs to the first organ downstream of the intravenous injection spot, has recently...


2019 ◽  
Vol 7 (5) ◽  
pp. 2050-2060 ◽  
Author(s):  
Jian Zhang ◽  
Zhu Qiao ◽  
Huan-Ying Liu ◽  
Jibin Song ◽  
Jun Yin

Tumor targeted size-switchable CPT/IR780@H30-PCL-PPI(L−)/PEI(–COOH/FA) nanoassembly with a “pomegranate” construction was designed, which could efficiently expand the penetration depth and accelerate the cell internalization.


Sign in / Sign up

Export Citation Format

Share Document